These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 21885181
1. Does azurin bind to the transactivation domain of p53? A Trp phosphorescence study. Gabellieri E, Bucciantini M, Stefani M, Cioni P. Biophys Chem; 2011 Dec; 159(2-3):287-93. PubMed ID: 21885181 [Abstract] [Full Text] [Related]
3. Interaction of p53 with Mdm2 and azurin as studied by atomic force spectroscopy. Funari G, Domenici F, Nardinocchi L, Puca R, D'Orazi G, Bizzarri AR, Cannistraro S. J Mol Recognit; 2010 Dec; 23(4):343-51. PubMed ID: 19941302 [Abstract] [Full Text] [Related]
4. Azurin modulates the association of Mdm2 with p53: SPR evidence from interaction of the full-length proteins. Domenici F, Frasconi M, Mazzei F, D'Orazi G, Bizzarri AR, Cannistraro S. J Mol Recognit; 2011 Dec; 24(4):707-14. PubMed ID: 21584881 [Abstract] [Full Text] [Related]
5. Structural characteristics of the hydrophobic patch of azurin and its interaction with p53: a site-directed spin labeling study. Xu C, Yin J, Zhao B. Sci China Life Sci; 2010 Oct; 53(10):1181-8. PubMed ID: 20953940 [Abstract] [Full Text] [Related]
6. Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy. Gao M, Zhou J, Su Z, Huang Y. Protein Sci; 2017 Dec; 26(12):2334-2341. PubMed ID: 28960574 [Abstract] [Full Text] [Related]
7. Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer. Yamada T, Goto M, Punj V, Zaborina O, Chen ML, Kimbara K, Majumdar D, Cunningham E, Das Gupta TK, Chakrabarty AM. Proc Natl Acad Sci U S A; 2002 Oct 29; 99(22):14098-103. PubMed ID: 12393814 [Abstract] [Full Text] [Related]
8. The interaction of azurin and C-terminal domain of p53 is mediated by nucleic acids. Xu C, Zhao Y, Zhao B. Arch Biochem Biophys; 2010 Nov 15; 503(2):223-9. PubMed ID: 20800053 [Abstract] [Full Text] [Related]
9. Modeling the interaction between the N-terminal domain of the tumor suppressor p53 and azurin. Taranta M, Bizzarri AR, Cannistraro S. J Mol Recognit; 2009 Nov 15; 22(3):215-22. PubMed ID: 19140135 [Abstract] [Full Text] [Related]
10. Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin. De Grandis V, Bizzarri AR, Cannistraro S. J Mol Recognit; 2007 Nov 15; 20(4):215-26. PubMed ID: 17703463 [Abstract] [Full Text] [Related]
11. The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53. Yamada T, Goto M, Punj V, Zaborina O, Kimbara K, Das Gupta TK, Chakrabarty AM. Infect Immun; 2002 Dec 15; 70(12):7054-62. PubMed ID: 12438386 [Abstract] [Full Text] [Related]
12. Bacterial cupredoxin azurin and its interactions with the tumor suppressor protein p53. Punj V, Das Gupta TK, Chakrabarty AM. Biochem Biophys Res Commun; 2003 Dec 05; 312(1):109-14. PubMed ID: 14630027 [No Abstract] [Full Text] [Related]
13. Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy. Bizzarri AR, Santini S, Coppari E, Bucciantini M, Di Agostino S, Yamada T, Beattie CW, Cannistraro S. Int J Nanomedicine; 2011 Dec 05; 6():3011-9. PubMed ID: 22162658 [Abstract] [Full Text] [Related]
14. Induction of apoptosis in macrophages by Pseudomonas aeruginosa azurin: tumour-suppressor protein p53 and reactive oxygen species, but not redox activity, as critical elements in cytotoxicity. Goto M, Yamada T, Kimbara K, Horner J, Newcomb M, Gupta TK, Chakrabarty AM. Mol Microbiol; 2003 Jan 05; 47(2):549-59. PubMed ID: 12519204 [Abstract] [Full Text] [Related]
15. Raman Evidence of p53-DBD Disorder Decrease upon Interaction with the Anticancer Protein Azurin. Signorelli S, Cannistraro S, Bizzarri AR. Int J Mol Sci; 2019 Jun 24; 20(12):. PubMed ID: 31238511 [Abstract] [Full Text] [Related]
16. Modelling the interaction between the p53 DNA-binding domain and the p28 peptide fragment of Azurin. Santini S, Bizzarri AR, Cannistraro S. J Mol Recognit; 2011 Jun 24; 24(6):1043-55. PubMed ID: 22038811 [Abstract] [Full Text] [Related]
17. Temperature and pressure dependence of azurin stability as monitored by tryptophan fluorescence and phosphorescence. The case of F29A mutant. Tognotti D, Gabellieri E, Morelli E, Cioni P. Biophys Chem; 2013 Dec 01; 182():44-50. PubMed ID: 23816248 [Abstract] [Full Text] [Related]
18. Probing the interaction between p53 and the bacterial protein azurin by single molecule force spectroscopy. Taranta M, Bizzarri AR, Cannistraro S. J Mol Recognit; 2008 Dec 01; 21(1):63-70. PubMed ID: 18247358 [Abstract] [Full Text] [Related]
19. Effects of cavity-forming mutations on the internal dynamics of azurin. Cioni P, de Waal E, Canters GW, Strambini GB. Biophys J; 2004 Feb 01; 86(2):1149-59. PubMed ID: 14747349 [Abstract] [Full Text] [Related]
20. Conformational changes in azurin from Pseudomona aeruginosa induced through chemical and physical protocols. Fuentes L, Oyola J, Fernández M, Quiñones E. Biophys J; 2004 Sep 01; 87(3):1873-80. PubMed ID: 15345565 [Abstract] [Full Text] [Related] Page: [Next] [New Search]